[Case Study] Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI

A year after launch, an emerging biopharmaceutical company focused on delivering groundbreaking cancer treatments saw an opportunity to improve its HCP targeting with more in depth analytics, particularly for high value HCPs. The biopharmaceutical company brought in Acorn AI, a Medidata company, to assess the situation and provide a solution.

Sponsored by: